Brasada Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.7M | Sell |
26,074
-947
| -4% | -$531K | 2.46% | 6 |
|
|
2026
Q1 | $15.6M | Sell |
27,021
-1,838
| -6% | -$1.18M | 2.86% | 5 |
|
|
2025
Q4 | $19.3M | Sell |
28,859
-1,426
| -5% | -$971K | 3.27% | 5 |
|
|
2025
Q3 | $19.2M | Sell |
30,285
-1,894
| -6% | -$1.15M | 3.24% | 5 |
|
|
2025
Q2 | $17.6M | Sell |
32,179
-658
| -2% | -$315K | 2.99% | 5 |
|
|
2025
Q1 | $11.9M | Buy |
32,837
+3,314
| +11% | +$1.44M | 2.36% | 9 |
|
|
2024
Q4 | $12.5M | Buy |
29,523
+5,636
| +24% | +$2.47M | 2.18% | 12 |
|
|
2024
Q3 | $11.6M | Buy |
23,887
+3,277
| +16% | +$1.59M | 2.03% | 15 |
|
|
2024
Q2 | $10.1M | Sell |
20,610
-226
| -1% | -$113K | 1.75% | 17 |
|
|
2024
Q1 | $11.2M | Buy |
20,836
+284
| +1% | +$155K | 1.99% | 14 |
|
|
2023
Q4 | $11.4M | Buy |
20,552
+514
| +3% | +$241K | 2.2% | 11 |
|
|
2023
Q3 | $8.86M | Buy |
20,038
+134
| +0.7% | +$66.8K | 2.07% | 12 |
|
|
2023
Q2 | $10M | Sell |
19,904
-91
| -0.5% | -$43.6K | 2.17% | 11 |
|
|
2023
Q1 | $10M | Sell |
19,995
-100
| -0.5% | -$47.9K | 2.23% | 11 |
|
|
2022
Q4 | $8.2M | Sell |
20,095
-70
| -0.3% | -$27.2K | 1.89% | 14 |
|
|
2022
Q3 | $6.57M | Buy |
20,165
+5,765
| +40% | +$2.12M | 1.56% | 19 |
|
|
2022
Q2 | $5.05M | Buy |
14,400
+70
| +0.5% | +$28.5K | 1.13% | 31 |
|
|
2022
Q1 | $7.84M | Sell |
14,330
-4,040
| -22% | -$2.13M | 1.48% | 22 |
|
|
2021
Q4 | $9.72M | Sell |
18,370
-21
| -0.1% | -$13.2K | 1.83% | 15 |
|
|
2021
Q3 | $11.4M | Sell |
18,391
-712
| -4% | -$478K | 2.24% | 12 |
|
|
2021
Q2 | $12.1M | Buy |
19,103
+93
| +0.5% | +$51.4K | 2.36% | 10 |
|
|
2021
Q1 | $9.3M | Buy |
19,010
+232
| +1% | +$116K | 2.01% | 12 |
|
|
2020
Q4 | $9.39M | Buy |
18,778
+160
| +0.9% | +$71.6K | 2.15% | 12 |
|
|
2020
Q3 | $7.32M | Sell |
18,618
-1,219
| -6% | -$451K | 1.85% | 13 |
|
|
2020
Q2 | $6.55M | Buy |
19,837
+241
| +1% | +$69.8K | 1.83% | 13 |
|
|
2020
Q1 | $4.75M | Buy |
19,596
+630
| +3% | +$164K | 1.7% | 21 |
|
|
2019
Q4 | $4.95M | Buy |
18,966
+420
| +2% | +$111K | 1.23% | 26 |
|
|
2019
Q3 | $5.04M | Buy |
18,546
+287
| +2% | +$79.9K | 1.35% | 22 |
|
|
2019
Q2 | $5.09M | Sell |
18,259
-22
| -0.1% | -$5.42K | 1.35% | 22 |
|
|
2019
Q1 | $4.09M | Sell |
18,281
-714
| -4% | -$147K | 1.22% | 24 |
|
|
2018
Q4 | $3.53M | Sell |
18,995
-4,345
| -19% | -$891K | 1.18% | 26 |
|
|
2018
Q3 | $5.83M | Sell |
23,340
-1,808
| -7% | -$439K | 1.61% | 19 |
|
|
2018
Q2 | $5.48M | Buy |
25,148
+2,362
| +10% | +$487K | 1.68% | 15 |
|
|
2018
Q1 | $4.36M | Sell |
22,786
-874
| -4% | -$161K | 1.36% | 23 |
|
|
2017
Q4 | $3.7M | Buy |
+23,660
| New | +$3.72M | 1.25% | 29 |
|
Other funds holding IDXX
Brasada Capital Management's IDXX Position: Q2 2026 in Review
Brasada Capital Management reduced its Idexx Laboratories (IDXX) stake by 3.5% in Q2 2026, selling an estimated $531K and leaving 26,074 shares worth $13.7M. The position accounts for 2.46% of the portfolio, ranked #6.
Brasada Capital Management first reported a position in IDXX in Q4 2017 and has held it in 35 quarters since. The position peaked at $19.3M in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Brasada Capital Management held 26,074 shares of Idexx Laboratories worth $13.7M as of Q2 2026.
- Brasada Capital Management sold 947 Idexx Laboratories shares in Q2 2026, an estimated $531K.
- Idexx Laboratories made up 2.46% of Brasada Capital Management's portfolio in Q2 2026, its #6 holding.
- Brasada Capital Management first reported a position in Idexx Laboratories in Q4 2017 and has held it in 35 quarters since.
- Brasada Capital Management's Idexx Laboratories position peaked at $19.3M in Q4 2025.
- 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Brasada Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.